Search

Your search keyword '"Gram, Inger T"' showing total 545 results

Search Constraints

Start Over You searched for: Author "Gram, Inger T" Remove constraint Author: "Gram, Inger T"
545 results on '"Gram, Inger T"'

Search Results

101. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension: a population-based intervention trial from the Tromso Study

102. High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium

105. Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium

106. Tumor-associated autoantibodies as early detection markers for ovarian cancer? : A prospective evaluation

107. Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

108. Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk : Results from the EPIC Cohort

109. Anti-CA15.3 and anti-CA125 antibodies and ovarian cancer risk : Results from the EPIC cohort

110. Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

111. Anti-CA15.3 and anti-CA125 antibodies and ovarian cancer risk: Results from the EPIC cohort

112. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation

113. Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort

115. Breast Cancer Risk After Recent Childbirth

116. Pre‐diagnostic circulating insulin‐like growth factor‐I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

117. Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC Cohort

118. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation

119. Smoking Cessation and Short- and Longer-Term Mortality.

121. Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies.

122. The Premenopausal Breast Cancer Collaboration : A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium.

123. The premenopausal breast cancer collaboration : A pooling project of studies participating in the national cancer institute cohort consortium

124. The premenopausal breast cancer collaboration: A pooling project of studies participating in the national cancer institute cohort consortium

125. Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort

126. An epidemiological model for prediction of endometrial cancer risk in Europe

127. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort

128. Combined effects of smoking and HPV16 in oropharyngeal cancer

130. The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium

132. Investigation of Dietary Factors and Endometrial Cancer Risk Using a Nutrient-wide Association Study Approach in the EPIC and Nurses' Health Study (NHS) and NHSII

133. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition

134. Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort

135. Ovarian Cancer Risk Factors by Histologic Subtype : An Analysis From the Ovarian Cancer Cohort Consortium

136. Combined effects of smoking and HPV16 in oropharyngeal cancer

137. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer : Results from the EPIC Cohort

138. An epidemiological model for prediction of endometrial cancer risk in Europe

139. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium

140. Combined effects of smoking and HPV16 in oropharyngeal cancer

141. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort

142. An epidemiological model for prediction of endometrial cancer risk in Europe

143. Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: Evidence from the EPIC cohort

144. Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort

145. Active and passive cigarette smoking and breast cancer risk: Results from the EPIC cohort

146. Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies

147. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium

150. Combined effects of smoking and HPV16 in oropharyngeal cancer

Catalog

Books, media, physical & digital resources